The LATAM Ledger: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The LATAM Ledger.

Press releases published on September 9, 2026

9 hours ago

AEON Announces Positive Pilot Forced Degradation Results Supporting Analytical Comparability of ABP-450 to BOTOX®

Indeterminate GlobeNewswire

9 hours ago

Electra Therapeutics Appoints Chris Clark, CFA, to Chief Financial Officer

Indeterminate GlobeNewswire

9 hours ago

American Gold & Copper Inc. (OTC: AGCI) Signs Definitive $10 Million Acquisition Agreement for 1,540-Acre Rimrock Copper-Gold Project in Nevada

Indeterminate GlobeNewswire

9 hours ago

Hudbay Recognized as a Top Performer by the Toronto Stock Exchange with Inclusion in the TSX30

Indeterminate GlobeNewswire

10 hours ago

NervGen to Host Inaugural R&D Day on September 30, 2026

Indeterminate GlobeNewswire

10 hours ago

Context Therapeutics Announces First Patient Dosed in Phase 1 Trial of CT-202

Indeterminate GlobeNewswire

10 hours ago

Avicanna Launches MyMedi.ca Integrated Healthcare Program in Canada

Indeterminate GlobeNewswire

10 hours ago

Onco360® Has Been Selected as Part of an Ultra-Narrow Specialty Pharmacy Network for MIMRYLO™ (rusfertide)

Indeterminate GlobeNewswire

10 hours ago

Koryx Copper Announces Further Drill Results at the Haib Copper Project in Southern Namibia

Indeterminate GlobeNewswire

10 hours ago

Cocrystal Pharma Announces Last Subject Dosed in Phase 1b Human Challenge Study Evaluating CDI-988 for Norovirus Prevention and Treatment

Indeterminate GlobeNewswire

10 hours ago

Actuate Announces Promising Preclinical Data Showing Synergistic Activity of Elraglusib in Combination with RAS Inhibitors Zoldonrasib and Daraxonrasib

Indeterminate GlobeNewswire

10 hours ago

Erdene Enters Into Automatic Securities Purchase Plan

Indeterminate GlobeNewswire

10 hours ago

MapLight Therapeutics to Participate in Upcoming Investor Conference

Indeterminate GlobeNewswire

10 hours ago

Pyxis Oncology Announces Positive Updated Data from Phase 1 Monotherapy Study of Micvotabart Pelidotin (MICVO) in Second-Line and Beyond Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (2L+ R/M HNSCC)

Indeterminate GlobeNewswire

10 hours ago

Fate Therapeutics Announces Encore Clinical Data Presentation of FT819 Off-the-Shelf CAR T-Cell Product Candidate at the CCR – West 2026 Meeting

Indeterminate GlobeNewswire

10 hours ago

Aya Gold & Silver Announces Updated PEA for Boumadine: After-Tax NPV Doubles to $3.5B with 93% IRR

Indeterminate GlobeNewswire

10 hours ago

OKYO Pharma to Present at Ophthalmology Futures European Forum and iNovation Day at ESCRS 2026

Indeterminate GlobeNewswire

11 hours ago

Telix to Present at the Morgan Stanley 24th Annual Global Healthcare Conference and H.C. Wainwright 28th Annual Global Investment Conference

Indeterminate GlobeNewswire

11 hours ago

Azimut Accelerates District-Scale Gold Exploration at Wabamisk

Indeterminate GlobeNewswire

11 hours ago

Azimut accélère l’exploration sur Wabamisk

Indeterminate GlobeNewswire